Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy

OBJECTIVES. The objective of this study was to evaluate the effect of tamoxifen on blood markers that are associated with cardiovascular risk, such as C-reactive protein (CRP), apolipoprotein A-1 (Apo-A), and apolipoprotein B-100 (Apo-B), in women undergoing chemotherapy for breast cancer. METHODS....

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Romero, Walckiria G., Da Silva, Fabrício B., Borgo, Mariana V., Bissoli, Nazaré S., Gouvêa, Sonia A., Abreu, Gláucia R.
Formato: Artigo
Idioma:Inglês
Publicado: AlphaMed Press 2012
Assuntos:
Breast Cancer
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336829/
https://ncbi.nlm.nih.gov/pubmed/22491005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0369
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares